Colorectal Cancer Treatment: Targeted Drug Therapy

Targeted Drug Therapy for Colorectal Cancer

In addition to standard chemotherapy for colorectal cancer, the cancer doctors at Cancer Treatment Centers of America (CTCA) also use targeted drugs to treat certain types of colorectal cancers. While traditional chemotherapy targets all cells in the body, targeted drug therapy helps direct chemotherapy drugs only to cancerous cells, which helps spare nearby healthy tissue.
 
Monoclonal antibody technology is an example of one prominent targeted drug therapy used for colorectal cancer treatment at CTCA. Monoclonal antibodies help leverage the body’s natural immune response to recognize, attack and destroy colorectal cancer cells. Monoclonal antibodies are bioengineered proteins that can be used alone, or in combination with other colorectal cancer therapies, to deliver drugs, toxins or radioactive material directly to cancer cells in your body.

Next Colorectal Cancer Treatment: Other Innovative Therapies

Colorectal Cancer